Literature DB >> 15907589

Direct oxidative DNA damage, apoptosis and radio sensitivity by spermine oxidase activities in mouse neuroblastoma cells.

R Amendola1, A Bellini, M Cervelli, P Degan, L Marcocci, F Martini, P Mariottini.   

Abstract

In mammals, the polyamines affect cell growth, differentiation, and apoptosis; their levels are increased in malignant and proliferating cells, thus justifying an interest in a chemotherapeutic approach to cancer. The flavoprotein SMO is the most recently characterized catabolic enzyme, preferentially oxidizing SPM to SPD, 3-aminopropanal and H(2)O(2). In this report, we describe a novel functional characterization of the recently cloned splice variant isoforms from mouse brain, encoding, among others, the nuclear co-localized spermine oxidase mSMOmu. The over-expression of the active isoforms mSMOalpha and mSMOmu, and the inactive mSMOdelta and mSMOgamma in mouse neuroblastoma cells, demonstrated the first evidence of the direct oxidative DNA damage by the SMO activities, either alone or, in a higher extent, when associated with radiation exposure, thus working as radio sensitizer. These effects were reverted by treatment with 50 muM and 100 muM doses of the inhibitor of SMO activity MDL 72,527. The over-expression of all SMO isoforms failed to influence the expression of the regulating enzymes of polyamines metabolism ODC and SSAT. Dealing with the unbalanced tissue specific SMO activities, these results could indicate a new direction to tailor chemotherapy-associated radiotherapy, improving dose-rate protocol and allowing the modulation of deleterious side effects on healthy tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907589     DOI: 10.1016/j.bbcan.2005.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

2.  Bridging the gap between plant and mammalian polyamine catabolism: a novel peroxisomal polyamine oxidase responsible for a full back-conversion pathway in Arabidopsis.

Authors:  Panagiotis N Moschou; Maite Sanmartin; Athina H Andriopoulou; Enrique Rojo; Jose J Sanchez-Serrano; Kalliopi A Roubelakis-Angelakis
Journal:  Plant Physiol       Date:  2008-06-26       Impact factor: 8.340

3.  Pharmacological Inhibition of Spermine Oxidase Reduces Neurodegeneration and Improves Retinal Function in Diabetic Mice.

Authors:  Fang Liu; Alan B Saul; Prahalathan Pichavaram; Zhimin Xu; Madhuri Rudraraju; Payaningal R Somanath; Sylvia B Smith; Ruth B Caldwell; S Priya Narayanan
Journal:  J Clin Med       Date:  2020-01-25       Impact factor: 4.241

Review 4.  Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?

Authors:  Esraa Shosha; Abdelrahman Y Fouda; S Priya Narayanan; R William Caldwell; Ruth B Caldwell
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

5.  The Impact of Spermidine on C2C12 Myoblasts Proliferation, Redox Status and Polyamines Metabolism under H2O2 Exposure.

Authors:  Roberta Ceci; Guglielmo Duranti; Stefano Giuliani; Marianna Nicoletta Rossi; Ivan Dimauro; Stefania Sabatini; Paolo Mariottini; Manuela Cervelli
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

6.  Treatment with polyamine oxidase inhibitor reduces microglial activation and limits vascular injury in ischemic retinopathy.

Authors:  C Patel; Z Xu; E Shosha; J Xing; R Lucas; R W Caldwell; R B Caldwell; S P Narayanan
Journal:  Biochim Biophys Acta       Date:  2016-05-27

Review 7.  Physiological polyamines: simple primordial stress molecules.

Authors:  H J Rhee; Eui-Jin Kim; J K Lee
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

8.  Targeting Polyamine Oxidase to Prevent Excitotoxicity-Induced Retinal Neurodegeneration.

Authors:  Prahalathan Pichavaram; Chithra Devi Palani; Chintan Patel; Zhimin Xu; Esraa Shosha; Abdelrahman Y Fouda; Ruth B Caldwell; Subhadra Priya Narayanan
Journal:  Front Neurosci       Date:  2019-01-10       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.